Banner of 2nd Pharmacovigilance Oversight and Inspection Readiness Summit, , March 27-28, 2023 - Le Meridien Philadelphia, PA, Achieve Safety Inspection Readiness Through Effective Partner Collaboration and Quality Optimization Strategies

Pharmacovigilance is responsible for the collection, assessment, identification, and communication of all drug safety information. In addition, PV focuses on the processing of safety information, adverse event reporting, and keeping up to date with guidelines and regulations.

The 2nd Pharmacovigilance Oversight and Inspection Readiness Summit will focus on how to achieve safety inspection readiness through effective partner collaboration and quality optimization strategies.

Interested in Risk Evaluation and Mitigation Strategy (REMS)?

Learn more about our 3rd REMS Innovation Summit Here




Logo of UBC


Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

To learn about sponsorship opportunities, please contact Meg Larson at

Top Reasons to Attend

Reason one to attend

Analyze the importance of a Culture of Quality and its impact on safety

Reason one to attend
Learn tools to “survive” Inspections and Audits
Reason one to attend
Ensure streamline communication between partners, CROs and sponsors
Reason one to attend
Leverage learnings and challenges from PV audits to promote and ensure inspection readiness
Reason one to attend
Discuss new ICH guidelines and their effect on drug safety and pharmacovigilance
Reason one to attend
Recognize the value of PV systems to streamline communication and achieve inspection readiness
Reason one to attend
Bridging the gap between PV innovation and PV quality
Reason one to attend
Explore innovative strategies in signal management and detection
Reason one to attend

Prioritize patient support programs


This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:
  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Health outcomes